ZEB2P1

Across TCGA pan-cancer cohorts, ZEB2P1 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated ZEB2P1 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher ZEB2P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZEB2P1 expression acts as an unfavorable survival marker, although some lineages such as ESCA and ACC show a favorable association.

STAD, ESCA, and ACC are the cancer types where ZEB2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Quartile	All	0.265	0.516	.003	54	view →
ESCA	DFS	Quartile	II,III,IV	0.499	0.210	.002	46	view →
ACC	OS	Tertile	III,IV	0.919	0.442	.014	41	view →
THCA	OS	Tertile	All	0.945	1.000	<.001	33	view →
HNSC	OS	Tertile	II,III,IV	0.537	0.756	.005	27	view →
KIRP	DFS	Quartile	All	0.739	0.917	.001	26	view →
PAAD	DFS	Quartile	All	0.645	0.429	.004	24	view →
BLCA	DFS	Tertile	III,IV	0.433	0.208	.004	19	view →
THYM	OS	Tertile	All	0.689	1.000	.005	16	view →
KICH	OS	Tertile	III,IV	0.309	0.879	.011	9	view →
LIHC	OS	Quartile	All	0.364	0.547	.005	9	view →
LUAD	DFS	Median	IV	0.346	0.580	.043	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

ZEB2P1–STAD (DFS)

Open the STAD breakdown →